In March 2025, the company announced new programs for the immediate-to-purchaser presenting of its Wegovy weight loss drug. The company founded a new pharmacy, called NovoCare, which would charge customers $499 monthly for use of the drug, fewer than 50 % the cost of the drug via other pharmaceutical distribution networks.[53]The subsequent table l